Varian Halcyon Treatment System Receives AERB Certificate for Import & Supply in India
New advanced cancer treatment system from Varian now available in India
PALO ALTO, California and MUMBAI, India, Feb. 6, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced the Halcyon™ cancer treatment platform has received Atomic Energy Regulatory Board (AERB) Certificate for Import and Supply in India. This registration allows Varian to now market this new system in India. Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT), and is well suited to treat a majority of cancer patients, offering advanced treatments for prostate, breast, head & neck, and many other forms of cancer.
"With AERB No Objection Certificate, clinicians in India now have access to Halcyon, which is engineered to revolutionize the clinical workflow and could help advance cost-effective cancer care across the country," said Ashok Kakkar, senior managing director, Varian India. "We look forward to continuing our close collaboration with clinical partners across India and helping realize a world without fear of cancer."
Halcyon is an advanced system that was designed to improve patient comfort, simplify operations, and shorten the time from installation to first-treatment without sacrificing quality. Its quiet operating environment, which is up to 2x quieter than other systems, has been designed with the patients in mind. Additionally, Halcyon has a low couch height for easy patient access, and soft indirect ambient lighting in the gantry opening.
Featuring a 100cm gantry opening, which is larger than those on standard CT machines, Halcyon is capable of rotations 4x faster than c-arm gantries for rapid imaging and treatment. The system is also capable of fast and sharp volumetric imaging in as little as 15 seconds. With Halcyon treatments, a complex image guided IMRT plan is clinically accelerated compared to those delivered on traditional devices.
Operationally, Halcyon features a streamlined workflow that only requires nine steps from the start to the end of treatment compared to up to more than 30 steps with older technologies. To assist in the reduction of time and construction costs from installation to first patient treatment, Halcyon comes pre-commissioned, requires less shielding than traditional systems, can fit in a vault as small as 5.9 meters (19.68 feet) x 5.539 meters (18.17 feet) x 2.743 meters (8.99 feet) high and can be installed in two weeks or less.
For more information on Halcyon visit www.varian.com/halcyon.
About Varian
Varian is a leader in developing and delivering cancer care solutions, and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Press Contact
Mark Plungy
Director, Public Relations
+1 (650) 424-5630
[email protected]
Investor Relations Contact
J. Michael Bruff
Vice President, Investor Relations
+1 (650) 424-5163
[email protected]
Share this article